Eosinophilic Myocarditis

Heart Failure Clinics

Volumn 1, Issue 3, 2005, Pages 419-429

  Ginsberg, Fredric ^a   Parrillo, Joseph E ^a,b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b Department of Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALPHA INTERFERON; AMITRIPTYLINE; AMPHOTERICIN; AMPICILLIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CEFACLOR; CHLORAMPHENICOL; CHLORTALIDONE; CLADRIBINE; CORTICOSTEROID; CYCLOSPORIN; DESIPRAMINE; DIURETIC AGENT; DOBUTAMINE; ETOPOSIDE; HYDROCHLOROTHIAZIDE; HYDROXYUREA; IMATINIB; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISONE; SMALLPOX VACCINE; UNINDEXED DRUG; VINCRISTINE;

ACUTE NECROTIZING EOSINOPHILIC MYOCARDITIS; AUTOPSY; CIRCULATION; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EOSINOPHIL; EOSINOPHIL MYOCARDITIS; HEART FAILURE; HEART MUSCLE BIOPSY; HUMAN; HYPEREOSINOPHILIC SYNDROME; MYOCARDITIS; PATHOGENESIS; REVIEW; THROMBOEMBOLISM; THROMBOSIS;

ANIMALS; CARDIOTONIC AGENTS; DOBUTAMINE; DRUG HYPERSENSITIVITY; EOSINOPHILS; HUMANS; HYPEREOSINOPHILIC SYNDROME; MYOCARDITIS; NECROSIS; SMALLPOX VACCINE;

EID: 33645985501     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2005.06.013     Document Type: Review

References (54)

1. French A.J., and Weller C.V. Interstitial myocarditis following the clinical and experimental use of sulfonamide drugs. Am J Pathol 18 (1942) 109-121
2. Pisani B., Taylor D., and Mason J. Inflammatory myocardial diseases and cardiomyopathies. Am J Med 102 (1997) 459-469
3. Zaacks S.M., Klein L., Tan C., et al. Hypersensitivity myocarditis associated with ephedra use. Clin Toxicol 37 4 (1999) 485-489
4. Fenoglio J., McAllister H., and Mullick F. Drug related myocarditis. I. Hypersensitivity myocarditis. Human Path 12 10 (1981) 900-907
5. Burke A., Saenger J., Mullick F., et al. Hypersensitivity myocarditis. Arch Pathol Lab Med 115 (1991) 764-769
6. Wynne J., and Braunwald E. The cardiomyopathies and myocarditises. In: Braunwald E. (Ed). Heart disease. A textbook of cardiovascular medicine (2001), W.B. Saunders Company, Philadelphia 1448-1449
7. Taliercio C., Olney B., and Lie J.T. Myocarditis related to drug hypersensitivity. Mayo Clin Proc 60 (1985) 463-468
8. Wu L., Cooper L.T., Kephart G.M., et al. The eosinophil in cardiac disease. In: Cooper L.T. (Ed). Myocarditis: from bench to bedside (2003), Humana Press, Totowa (NJ) 437-453
9. Galiuto L., Enriquez-Sarano M., Reeder G., et al. Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment. Mayo Clin Proc 72 7 (1997) 603-610
10. Herzog C., Snover D., and Staley N. Acute necrotising eosinophilic myocarditis. B Heart J 52 (1984) 343-348
11. Salzman M., Valderrama E., and Sood S. Carbamazepine and fatal eosinophilic myocarditis. N Engl J Med 336 (1997) 878-879
12. Kazama R., Okura Y., Hoyano M., et al. Therapeutic role of pericardiocentesis for acute necrotizing eosinophilic myocarditis with cardiac tamponade. Mayo Clin Proc 78 (2003) 901-907
13. Chun W., Grist T., Kamp T., et al. Infiltrative eosinophilic myocarditis diagnosed and localized by cardiac magnetic resonance imaging. Circulation 110 (2004) e19
14. Aggarwal A., Bergin P., Jessup P., et al. Hypersensitivity myocarditis presenting as cardiogenic shock. J Heart Lung Transplant 20 (2001) 1241-1244
15. Parrillo J.E. Heart disease and the eosinophil. N Engl J Med 323 (1990) 1560-1561
16. Getz M., Subramanian R., Logemann T., et al. Acute necrotizing eosinophilic myocarditis as a manifestation of severe hypersensitivity myocarditis. Ann Intern Med 115 (1991) 201-202
17. Hayashai S., Furuya S., and Imamura H. Fulminant eosinophilic endomyocarditis in an asthmatic patient treated with pranlukast after corticosteroid withdrawal. Heart 86 (2001) e7-e9
18. Adsett M., West M., Galbraith A., et al. Eosinophilic heart: marked left ventricular wall thickening and myocardial dysfunction improving with corticosteroid therapy. Echocardiography 20 (2003) 369-374
19. Cassimatis D., Atwood J.E., Engler R., et al. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol 43 (2004) 1503-1510
20. Halsell J., Riddle J., Atwood J.E., et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 289 (2003) 3283-3289
21. Murphy J., Wright R., Bruce G.K., et al. Eosinophilic lymphocytic myocarditis after smallpox vaccination. Lancet 362 (2003) 1378-1380
22. Boccara F., Benhaiem-Sigaux N., and Cohen A. Acute myopericarditis after diphtheria, tetanus, and polio vaccination. Chest 120 (2001) 671-672
23. Spear G.S. Eosinophilic explant carditis with eosinophilia: hypersensitivity to dobutamine infusion. Jnl Hrt Lung Transplant 14 (1995) 755-760
24. Hawkins E.T., Levine T.B., Goss S.J., et al. Hypersensitivity myocarditis in the explanted heart of transplant recipients. Pathol Ann 30 pt 1 (1995) 287-304
25. Takkenberg J.J., Czer L.S., Fishbein M.C., et al. Eosinophilic myocarditis in patients awaiting heart transplantation. Crit Care Med 32 (2004) 714-721
26. Johnson M.R. Eosinophilic myocarditis in the explanted hearts of cardiac transplant recipients: interesting pathologic finding or pathophysiologic entity of clinical significance?. Crit Care Med 32 3 (2004) 888-890
27. Bilinska Z.T., Bilinska M., Grzybowski J., et al. Unexpected eosinophilic myocarditis in a young woman with rapidly progressive dilated cardiomyopathy. Int J Cardiol 86 (2002) 295-297
28. Butany J., Nair V., Ahluwalia M.S., et al. Hypersensitivity myocarditis complicating hypertrophic cardiomyopathy heart. Can J Cardiol 20 9 (2004) 911-914
29. El-Sayed O.M., Abdelfattah R.R., Barcelona R., et al. Dobutamine-induced eosinophilia. Am J Cardiol 93 (2004) 1078-1079
30. di Gioia C., d'Amati G., Grillo P., et al. Eosinophilic infiltration immediately following transplantation: recurrent hypersensitivity reaction?. Cardiovas Path 8 5 (1999) 297-299
31. Weller P.F., and Bubley G.J. The idiopathic hypereosinophilic syndrome. Blood 83 (1994) 2759-2779
32. Tefferi A. Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment. Mayo Clin Proc 80 1 (2005) 75-83
33. Parrillo J.E., Borer J.S., Henry W.L., et al. The cardiovascular manifestations of the hypereosinophilic syndrome. Am J Med 67 (1979) 572-582
34. Spry C., Take M., and Tai P. Eosinophilic disorders affecting the myocardium and endocardium: a review. Heart Vessels Suppl 1 (1985) 240-242
35. Corradi D., Vaglio A., Maestri R., et al. Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol 35 (2004) 1160-1163
36. Sato Y., Taniguchi R., Yamada T., et al. Measurement of serum concentrations of cardiac troponin T in patients with hypereosinophilic syndrome: a sensitive non-invasive marker of cardiac disorder. Int Med 39 (2000) 350
37. Ommen S., Seward J., and Tajik A. Clinical and echocardiographic features of hypereosinophilic syndrome. Am J Cardiol 86 (2000) 110-113
38. Parrillo J.E., Fauci A.S., and Wolff S.M. Therapy of the hypereosinophilic syndrome. Ann Intern Med 89 2 (1978) 167-172
39. Fauci A.S., Harley J.B., Roberts W.C., et al. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97 (1982) 78-92
40. Rothenberg M. Eosinophilia. N Engl J Med 338 32 (1998) 1592-1600
41. Ascione L., DeMichele M., Accadia M., et al. Reversal of cardiac abnormalities in a young man with idiopathic hypereosinophilic syndrome using a tyrosine kinase inhibitor. Euro J Echo 5 (2004) 386-390
42. Blake D.P., Palmer T.E., and Olinger G.N. Mitral valve replacement in idiopathic hypereosinophilic syndrome. J Thorac Cardiovasc Surg 89 (1985) 630-638
43. Watanabe K., Olivier T., Lionel F., et al. Recurrent thrombosis of prosthetic mitral valve in idiopathic hypereosinophilic syndrome. J Heart Valve Dis 11 (2002) 447-449
44. Fuzellier J.F., Chapoutot L., and Torossian P.F. Mitral valve repair in idiopathic hypereosinophilic syndrome. J Heart Valve Dis 13 (2004) 529-531
45. Olsen E., and Spry C. Relation between eosinophilia and endomyocardial disease. Prog Cardiovas Dis 27 (1985) 241-254
46. Davies J.N.P. Endomyocardial necrosis: a heart disease of obscure aetiology in Africans. MD thesis (1948), University of Bristol
47. Davies J.N.P. African endomyocardial fibrosis. In: Brest A.N., and Burch G.E. (Eds). Cardiomyopathy, cardiovascular clinics Vol. 4 (1972), FA Davis, Philadelphia 345-359
48. Ramakrishna G., Connolly H., Tazelaar H., et al. Churg-Strauss syndrome complicated by eosinophilic endomyocarditis. Mayo Clin Proc 75 (2000) 631-635
49. Lie J.T., and Bayardo R.J. Isolated eosinophilic coronary arteritis and eosinophilic myocarditis. A limited forum of Churg-Strauss Syndrome. Arch Pathol Lab Med 113 (1989) 199-201
50. Parrillo J.E., and Fauci A.S. Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome. Blood 51 3 (1978) 457-473
51. Young J.D., Peterson C., Venge P., et al. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321 (1986) 613-616
52. Arima M., and Kanoh T. Eosinophilic myocarditis associated with dense deposits of eosinophil cationic protein (ECP) in endomyocardium with high serum ECP. Heart 81 (1999) 669-675
53. DeMello D., Liapis H., Jureidini S., et al. Cardiac localization of eosinophil granule major basic protein in acute necrotizing myocarditis. N Engl J Med 323 (1990) 1542-1545
54. Case Records of the Massachusetts General Hospital (Case 30-2000). A 25-year-old man with asthma, cardiac failure, diarrhea, and weakness of the right hand. N Engl J Med 343 (2000) 953-961 [erratum in N Engl J Med 2000;343(21):1584]